Kasturi Banerjee: h-index, Total Citations, and Citation Map
Kasturi Banerjee's h-index is 8 (8 i10-index, 765+ total citations across 16+ publications) according to Google Scholar as of May 2026. Kasturi Banerjee is affiliated with Senior Clinical Scientist.
Kasturi Banerjee is a researcher affiliated with Senior Clinical Scientist, specializing in Immunology, Immunotherapy, Infectious Diseases. Their work has been cited 765 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Kasturi Banerjee's Citation Metrics
Bibliometric impact based on 16 indexed publications.
- H-Index
- 8
- i10-Index
- 8
- Total Citations
- 765
- Citing Countries
- 61
As of May 2026.
Kasturi Banerjee has an h-index of 8 and 765 total citations across 16 publications, with research cited by institutions in 61 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Kasturi Banerjee's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
Cancer-associated mucins: role in immune modulation and metastasis
2019280+17
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
20 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher advanced pancreatic cancer immunotherapy by establishing a foundational review of emerging trends and subsequently developing targeted MUC4 nanovaccines to induce durable T cell responses.
The researcher established the critical role of IgG subclasses in antibody-mediated protection against carbapenem-resistant Klebsiella pneumoniae, subsequently developing broadly cross-protective monoclonal antibodies from patient-derived data.
The researcher advanced monoclonal antibody-based therapies for bacterial infections, establishing a foundational framework widely adopted by the independent scientific community.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
